Abstract
Pulmonary hypertension is a serious clinical condition characterised by increased pulmonary arterial pressure. This can lead to right ventricular failure which can be fatal. Connexins are gap junction-forming membrane proteins which serve to exchange small molecules of less than 1 kD between cells. Connexins can also form hemi-channels connecting the intracellular and extracellular environments. Hemi-channels can mediate adenosine triphosphate release and are involved in autocrine and paracrine signalling. Recently, our group and others have identified evidence that connexin-mediated signalling may be involved in the pathogenesis of pulmonary hypertension. In this review, we discuss the evidence that dysregulated connexin-mediated signalling is associated with pulmonary hypertension.
Original language | English |
---|---|
Article number | 379 |
Number of pages | 11 |
Journal | International Journal of Molecular Sciences |
Volume | 23 |
Issue number | 1 |
Early online date | 29 Dec 2021 |
DOIs | |
Publication status | Published - Jan 2022 |
Keywords
- pulmonary hypertension; connexins; gap junctions; vascular remodelling; hypoxic vasoconstriction; vascular reactivity; right ventricular hypertrophy
- signal transduction
- humans
- hypertension, pulmonary/metabolism
- gap junctions/metabolism
- animals
- connexins/metabolism
- disease models, animal
ASJC Scopus subject areas
- Molecular Biology
- Spectroscopy
- Catalysis
- Inorganic Chemistry
- Computer Science Applications
- Physical and Theoretical Chemistry
- Organic Chemistry